Edwards Lifesciences Corp — Director's Dealing 2010

Feb 16, 2010

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2009-12-31

Reporting Person: BOBO DONALD E JR (CVP, Heart Valve Therapy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-11-24	Common Stock	G	350	—	Disposed	16263	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2091	Indirect

Footnotes

F1: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.

F2: Shares represented on the most recent statement of the 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equities to share equivalents.